Present status of lung cancer chemotherapy in Japan.
Present status of lung cancer chemotherapy in Japan.
复制标题
日本肺癌化疗现状。
DOI：
10.1007/978-3-642-81392-4_18
复制
发表时间：
1980
期刊：
影响因子：
--
通讯作者：
M. Nishimura
中科院分区：
文献类型：
--
作者：
K. Ota;M. Nishimura
肺癌是最难治愈的癌症之一，因为早期诊断和早期治愈治疗比胃肠道癌症更困难。由于内窥镜检查的引入，在过去10年中，日本的胃癌，特别是早期癌症的诊断取得了很大进展。爱知癌症中心医院近10年来收治的809例肺癌患者中，只有26.5%接受了手术治疗，仅16.5%接受了肿瘤切除术。因此，很明显，化疗和/或放疗在治疗恶性肿瘤中是重要的。本文就日本肺癌化疗的进展作一简要综述。
Lung cancer is one of the most difficult cancers to cure, because early diagnosis and early curative treatment are more difficult than in gastrointestinal cancer. Diagnosis of gastric cancer, especially early cancer, has made great progress in Japan in the past 10 years due to the introduction of endoscopy. Only 26.5% of 809 p~ tients with lung cancer were operated on during the past 10 years in Aichi Cancer Center Hospital, and curative rc; section oftumors was undertaken in only 16.5% of the total number of patients. Thus, it is apparent that chemotherapy and/or radiotherapy are important in the treatment oflung cancer. This paper presents a short review of the progress in the field of lung cancer chemotherapy in Japan.